CEO
GlaxoSmithKline

Andrew became Chief Executive Officer of GlaxoSmithKline plc on 21 May 2008. He is a member of the Board and Corporate Executive Team.

Andrew joined Glaxo in 1985 and has held a variety of Sales and Marketing roles in the UK and abroad including working in the Company’s International New Products groups, both in the Respiratory and HIV/Infectious disease fields. Outside of the UK Andrew has worked in South Africa, the USA and Singapore where he led the Group’s operations as Senior Vice President, Asia Pacific. While in Singapore Andrew was a Board Member of the Singapore Economic Development Board and the Singapore Land Authority. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star.

In 2003 Andrew was appointed President of GSK Europe and joined GSK’s Corporate Executive Team.

Andrew has served in numerous advisory roles to Governments around the world including South Africa, Singapore, Guangzhou China and the UK, where he was a member of the Prime Minister’s Business Advisory Group from 2010 – 2015. He was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry in the 2012 New Year Honours List. In 2014, Andrew was appointed to be a Business Ambassador for the UK Government.

Andrew is Chancellor of the University of Nottingham, a position he took up on 1 January 2013.

Andrew has a Joint Honours BA in Economics from the University of Nottingham.